OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Formulation and Delivery Technologies for mRNA Vaccines
Chunxi Zeng, Chengxiang Zhang, Patrick Walker, et al.
Current topics in microbiology and immunology (2020), pp. 71-110
Open Access | Times Cited: 179
Chunxi Zeng, Chengxiang Zhang, Patrick Walker, et al.
Current topics in microbiology and immunology (2020), pp. 71-110
Open Access | Times Cited: 179
Showing 51-75 of 179 citing articles:
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections
Hong You, Malcolm K. Jones, Catherine A. Gordon, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 22
Hong You, Malcolm K. Jones, Catherine A. Gordon, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 22
Use of stimulatory responsive soft nanoparticles for intracellular drug delivery
Krystal A. Hughes, Bishal Misra, Maryam Maghareh, et al.
Nano Research (2023) Vol. 16, Iss. 5, pp. 6974-6990
Open Access | Times Cited: 18
Krystal A. Hughes, Bishal Misra, Maryam Maghareh, et al.
Nano Research (2023) Vol. 16, Iss. 5, pp. 6974-6990
Open Access | Times Cited: 18
Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges
Chloe Forenzo, Jessica Larsen
Molecular Pharmaceutics (2023) Vol. 20, Iss. 9, pp. 4387-4403
Closed Access | Times Cited: 17
Chloe Forenzo, Jessica Larsen
Molecular Pharmaceutics (2023) Vol. 20, Iss. 9, pp. 4387-4403
Closed Access | Times Cited: 17
RNA nanostructures for targeted drug delivery and imaging
Laura Teodori, Marjan Omer, Jørgen Kjems
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-19
Open Access | Times Cited: 7
Laura Teodori, Marjan Omer, Jørgen Kjems
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-19
Open Access | Times Cited: 7
Nano-Microparticle Platforms in Developing Next-Generation Vaccines
Giuseppe Cappellano, Hugo Abreu, Chiara Casale, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 606-606
Open Access | Times Cited: 40
Giuseppe Cappellano, Hugo Abreu, Chiara Casale, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 606-606
Open Access | Times Cited: 40
Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action
Giulietta Maruggi, Jeffrey B. Ulmer, Rino Rappuoli, et al.
Current topics in microbiology and immunology (2021), pp. 31-70
Closed Access | Times Cited: 35
Giulietta Maruggi, Jeffrey B. Ulmer, Rino Rappuoli, et al.
Current topics in microbiology and immunology (2021), pp. 31-70
Closed Access | Times Cited: 35
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Jürgen Held, Jan Esse, Koray Taşçılar, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1063-1063
Open Access | Times Cited: 35
Jürgen Held, Jan Esse, Koray Taşçılar, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1063-1063
Open Access | Times Cited: 35
Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
Nusrat Zahan Rouf, Sumit Biswas, Nawseen Tarannum, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 386-410
Open Access | Times Cited: 27
Nusrat Zahan Rouf, Sumit Biswas, Nawseen Tarannum, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 386-410
Open Access | Times Cited: 27
Current Vaccine Platforms in Enhancing T-Cell Response
Takehiro Ura, Masaki Takeuchi, Tatsukata Kawagoe, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 27
Takehiro Ura, Masaki Takeuchi, Tatsukata Kawagoe, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 27
Viral vector and nucleic acid vaccines against COVID-19: A narrative review
Saeed Khoshnood, Roya Ghanavati, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 27
Saeed Khoshnood, Roya Ghanavati, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 27
Bioinformatics, Computational Informatics, and Modeling Approaches to the Design of mRNA COVID-19 Vaccine Candidates
Olugbenga Oluwagbemi, Elijah Kolawole Oladipo, Olatunji Matthew Kolawole, et al.
Computation (2022) Vol. 10, Iss. 7, pp. 117-117
Open Access | Times Cited: 24
Olugbenga Oluwagbemi, Elijah Kolawole Oladipo, Olatunji Matthew Kolawole, et al.
Computation (2022) Vol. 10, Iss. 7, pp. 117-117
Open Access | Times Cited: 24
mRNA vaccines induce rapid antibody responses in mice
Makda S. Gebre, Susanne Rauch, Nicole Roth, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 24
Makda S. Gebre, Susanne Rauch, Nicole Roth, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 24
Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules
Jingjing Zhang, Yuheng Liu, Chao Li, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2182-2182
Open Access | Times Cited: 15
Jingjing Zhang, Yuheng Liu, Chao Li, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2182-2182
Open Access | Times Cited: 15
The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
Yahya F. Jamous, Dalal A Alhomoud
Cureus (2023)
Open Access | Times Cited: 14
Yahya F. Jamous, Dalal A Alhomoud
Cureus (2023)
Open Access | Times Cited: 14
Path towards mRNA delivery for cancer immunotherapy from bench to bedside
Wenfei Chen, Yining Zhu, Jinhan He, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 96-115
Open Access | Times Cited: 14
Wenfei Chen, Yining Zhu, Jinhan He, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 96-115
Open Access | Times Cited: 14
RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
Mohammad Natami, Amirsasan Gorgzadeh, Arsalan Gholipour, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Mohammad Natami, Amirsasan Gorgzadeh, Arsalan Gholipour, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
mRNA-based vaccines – global approach, challenges, and could be a promising wayout for future pandemics
Shivani Makhijani, Gehan M. Elossaily, Satish Rojekar, et al.
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 6, pp. 559-565
Closed Access | Times Cited: 6
Shivani Makhijani, Gehan M. Elossaily, Satish Rojekar, et al.
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 6, pp. 559-565
Closed Access | Times Cited: 6
Nucleic Acid Armor: Fortifying RNA Therapeutics through Delivery and Targeting Innovations for Immunotherapy
Yi Jiang, Bolong Jiang, Zhenru Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8888-8888
Open Access | Times Cited: 6
Yi Jiang, Bolong Jiang, Zhenru Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8888-8888
Open Access | Times Cited: 6
Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transfer
Ana Krhač Levačić, Simone Berger, Judith Müller, et al.
Journal of Controlled Release (2021) Vol. 339, pp. 27-40
Closed Access | Times Cited: 32
Ana Krhač Levačić, Simone Berger, Judith Müller, et al.
Journal of Controlled Release (2021) Vol. 339, pp. 27-40
Closed Access | Times Cited: 32
Delivery of synthetic mRNAs for tissue regeneration
Heidrun Steinle, Marbod Weber, Sandra Stoppelkamp, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114007-114007
Closed Access | Times Cited: 31
Heidrun Steinle, Marbod Weber, Sandra Stoppelkamp, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114007-114007
Closed Access | Times Cited: 31
Emerging Phospholipid Nanobiomaterials for Biomedical Applications to Lab-on-a-Chip, Drug Delivery, and Cellular Engineering
Maedeh Rahimnejad, Navid Rabiee, Sepideh Ahmadi, et al.
ACS Applied Bio Materials (2021) Vol. 4, Iss. 12, pp. 8110-8128
Closed Access | Times Cited: 29
Maedeh Rahimnejad, Navid Rabiee, Sepideh Ahmadi, et al.
ACS Applied Bio Materials (2021) Vol. 4, Iss. 12, pp. 8110-8128
Closed Access | Times Cited: 29
Advances in mRNA vaccines
Mengyun Li, Zining Wang, C. Xie, et al.
International review of cell and molecular biology (2022), pp. 295-316
Open Access | Times Cited: 22
Mengyun Li, Zining Wang, C. Xie, et al.
International review of cell and molecular biology (2022), pp. 295-316
Open Access | Times Cited: 22
Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer
Noelia Silva-Pilipich, Aritz Lasarte-Cía, Teresa Lozano, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 387-399
Open Access | Times Cited: 20
Noelia Silva-Pilipich, Aritz Lasarte-Cía, Teresa Lozano, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 387-399
Open Access | Times Cited: 20
Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines
Feng Lin, Emma Z. Lin, Misa Anekoji, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Feng Lin, Emma Z. Lin, Misa Anekoji, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model
Dorien De Pooter, Wim Pierson, Soheil Pourshahian, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 237-237
Open Access | Times Cited: 4
Dorien De Pooter, Wim Pierson, Soheil Pourshahian, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 237-237
Open Access | Times Cited: 4
